Product Details

Lotriderm Cream

Clotrimazole + Betamethasone Dipropionate
1% w/w + 0.05% w/w
Topical Cream


DIN/PIN/NPN

00611174

Manufacturer

Merck Canada Inc.

Formulary Listing Date

2020-06-30  

Unit Price

NA

Amount MOH Pays

NA

Coverage Status

Off-Formulary Interchangeable

ODB Formulary Therapeutic Classification

Therapeutic Note

Anti-Infectives, Fungicides (84:04:08): Due to its efficacy and significantly lower cost, clotrimazole should be the first line of treatment for Tinea corporis and cruris. In Tinea pedis, topical terbinafine should be considered the first line of treatment due to its efficacy and lower rate of relapse.

ATC Code

D01AC20

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02496410 TaroClotrimazole/BetamethasoneDipropiona 1.0578 NA
00611174 Lotriderm Cream NA NA
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph